» Articles » PMID: 11029462

Molecular Cloning and Characterization of a Human Beta-Gal-3'-sulfotransferase That Acts on Both Type 1 and Type 2 (Gal Beta 1-3/1-4GlcNAc-R) Oligosaccharides

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Oct 13
PMID 11029462
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A novel sulfotransferase gene (designated GP3ST) was identified on human chromosome 2q37.3 based on its similarity to the cerebroside 3'-sulfotransferase (CST) cDNA (Honke, K., Tsuda, M., Hirahara, Y., Ishii, A., Makita, A., and Wada, Y. (1997) J. Biol. Chem. 272, 4864-4868). A full-length cDNA was obtained by reverse transcription-polymerase chain reaction and 5'- and 3'-rapid amplification of cDNA ends analyses of human colon mRNA. The isolated cDNA clone predicts that the protein is a type II transmembrane protein composed of 398 amino acid residues. The amino acid sequence indicates 33% identity to the human CST sequence. A recombinant protein that is expressed in COS-1 cells showed no CST activity, but did show sulfotransferase activities toward oligosaccharides containing nonreducing beta-galactosides such as N-acetyllactosamine, lactose, lacto-N-tetraose (Lc4), lacto-N-neotetraose (nLc4), and Gal beta 1-3GalNAc alpha-benzyl (O-glycan core 1 oligosaccharide). To characterize the cloned sulfotransferase, a sulfotransferase assay method was developed that uses pyridylaminated (PA) Lc4 and nLc4 as enzyme substrates. The enzyme product using PA-Lc4 as an acceptor was identified as HSO(3)-3Gal beta 1-3GlcNAc beta 1-3Gal beta 1- 4Glc-PA by two-dimensional (1)H NMR. Kinetics studies suggested that GP3ST is able to act on both type 1 (Gal beta 1-3GlcNAc-R) and type 2 (Gal beta 1-4GlcNAc-R) chains with a similar efficiency. In situ hybridization demonstrated that the GP3ST gene is expressed in epithelial cells lining the lower to middle layer of the crypts in colonic mucosa, hepatocytes surrounding the central vein of the liver, extravillous cytotrophoblasts in the basal plate and septum of the placenta, renal tubules of the kidney, and neuronal cells of the cerebral cortex. The results of this study indicate the existence of a novel beta-Gal-3'-sulfotransferase gene family.

Citing Articles

In Silico Structural Modeling and Binding Site Analysis of Cerebroside Sulfotransferase (CST): A Therapeutic Target for Developing Substrate Reduction Therapy for Metachromatic Leukodystrophy.

Singh N, Singh A ACS Omega. 2024; 9(9):10748-10768.

PMID: 38463293 PMC: 10918841. DOI: 10.1021/acsomega.3c09462.


3'-sulfated Lewis: An oncofetal epitope associated with metaplastic and oncogenic plasticity of the gastrointestinal foregut.

Das K, Brown J Front Cell Dev Biol. 2023; 11:1089028.

PMID: 36866273 PMC: 9971977. DOI: 10.3389/fcell.2023.1089028.


Inhibition of galectins in cancer: Biological challenges for their clinical application.

Laderach D, Compagno D Front Immunol. 2023; 13:1104625.

PMID: 36703969 PMC: 9872792. DOI: 10.3389/fimmu.2022.1104625.


The Expression Profiles and Deregulation of UDP-Glycosyltransferase () Genes in Human Cancers and Their Association with Clinical Outcomes.

Hu D, Marri S, Mackenzie P, Hulin J, McKinnon R, Meech R Cancers (Basel). 2021; 13(17).

PMID: 34503303 PMC: 8430925. DOI: 10.3390/cancers13174491.


Novel lamprey antibody recognizes terminal sulfated galactose epitopes on mammalian glycoproteins.

McKitrick T, Bernard S, Noll A, Collins B, Goth C, McQuillan A Commun Biol. 2021; 4(1):674.

PMID: 34083726 PMC: 8175384. DOI: 10.1038/s42003-021-02199-7.